SeraNovo has signed a License Agreement with Carna Biosciences Inc.
SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences Inc., a company engaged in drug development specializing in the development of kinase inhibitors. Under the agreement, the companies […]